LENTIGEN CORP has a total of 18 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BIO PATH HOLDINGS INC, HUAIAN KANGYILAI STEM CELL BIOTECHNOLOGY CO LTD and ABRAHAM J AND PHYLLIS KATZ CORD BLOOD FOUND.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 3 | |
#4 | China | 2 | |
#5 | Japan | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Dropulic Boro | 16 |
#2 | Chang Yung Nien | 8 |
#3 | Boro Dropulic | 2 |
#4 | Chang Yung-Nien | 1 |
#5 | Baranyi Lajos | 1 |
Publication | Filing date | Title |
---|---|---|
CA2825032A1 | Advanced prime and boost vaccine | |
CA2754603A1 | Non-integrating retroviral vector vaccines | |
WO2010051521A1 | Cell therapy product for the treatment of hiv infection | |
WO2009142767A1 | Lentivector-based protein production | |
WO2007133674A2 | Lentiviral vector compositions, methods and applications | |
WO2006089001A2 | Lentiviral vectors and their use | |
CN101160055A | Lentiviral vectors and their use |